Patents Examined by Thomas W Prasthofer
  • Patent number: 6337325
    Abstract: A combination preparation comprising a compound which has a phosphodiesterase-inhibiting action, and a compound which reduces the biologically effective intracellular Ca2+ content, is suitable for the treatment of immunological diseases.
    Type: Grant
    Filed: July 20, 1999
    Date of Patent: January 8, 2002
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Martin Schönharting, Stefan Müllner, Peter Zabel